Compare MasterCard Inc (MA) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasterCard Inc vs Tenet Healthcare Corporation — how do they compare? MasterCard Inc trades at $541.65 (market cap $480.32B), while Tenet Healthcare Corporation trades at $194.91 (market cap $16.79B). The key difference: MasterCard Inc is far larger — about 28.6× Tenet Healthcare Corporation's market cap, and MasterCard Inc pays a 0.64% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| MA | THC | |
|---|---|---|
Market Cap | $480.32B | $16.79B |
Volume | 4,635,698 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $598.96 | $244.80 |
52-Week Low | $471.55 | $148.38 |
Enterprise Value | $491.06B | $27.03B |
Dividend Yield | 0.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $543.6, down 1.44% on the day, with strong bullish technical signals and consistent earnings beats. The company demonstrates robust fundamentals with 2025 revenue of $32.79B and net income of $14.97B, maintaining high profit margins above 45%. Recent institutional buying activity and a unanimous analyst buy consensus (79% buy rating) with a $634.27 price target suggest strong institutional confidence.
Outlook remains positive given Mastercard's consistent revenue growth, expanding digital payment initiatives, and dominant market position. Key risks include payment industry disruption from stablecoins and AI agents, competitive pressure from Visa, and regulatory scrutiny. The stock's premium valuation (P/E 31.46) requires sustained execution, but strong cash flow generation and strategic investments support long-term growth potential.
Tenet Healthcare (THC) trades at $194.91, down 2.15% on the day, but maintains a bullish technical signal with strong analyst support. The stock exhibits solid fundamentals, including a low P/E of 10.14 and robust profitability with a net income margin of 7.79%. Recent earnings have consistently beaten expectations, and the company's Ambulatory Care segment is a key growth driver, as highlighted by Zacks Investment Research on 2026-07-01.
The outlook for THC is positive, with a consensus price target of $235.88 implying significant upside. Investment opportunities stem from earnings momentum and outpatient expansion, though risks include healthcare regulatory pressures and market volatility. The stock's current valuation presents a compelling entry point for growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
